The Systemic Aspergillosis and Systemic Candidasis Market size is projected to reach US$ 10.03 billion by 2031 from US$ 6.73 billion in 2023. The market is expected to register a CAGR of 4.1% in 2023–2031.

The systemic aspergillosis and systemic candidiasis market is expanding due to rising fungal infections, increasing immunocompromised populations, and advancements in antifungal therapies. Key drivers include improved diagnostics and growing awareness of fungal diseases. Challenges include antifungal resistance, high treatment costs, and limited access to advanced therapies in developing regions.

 Source: The Insight Partners